A subsequent study showed that DAXX promotes ovarian cancer ascites cell proliferation by activating the ERK pathway and directly binding to CCAAT enhancer binding protein-beta (CEBP-β) (122). The gene discussed is CEBPB; the disease is ovarian carcinoma.